Muminov Temur K, Gushchin Vladimir A, Kleymenov Denis A, Tkachuk Artem P, Manuylov Viktor A, Siniavin Andrei E, Ogarkova Daria A, Kuznetsova Nadezhda A, Zlobin Vladimir I, Gintsburg Alexander L
Federal State Budget Institution "National Research Centre for Epidemiology and Microbiology Named after Honorary Academician N. F. Gamaleya" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Department of Medical Genetics, I. M. Sechenov First Moscow State Medical University, Moscow, Russia.
Front Immunol. 2025 Aug 8;16:1525388. doi: 10.3389/fimmu.2025.1525388. eCollection 2025.
Tick-borne encephalitis (TBE) is a significant public health challenge in Russia. Vaccination is one of the most effective measures to control TBE. The aim of our study was to assess the state of anti-TBE virus population immunity, including artificial post-vaccine and natural post-infection immunity, in the context of characteristics of the epidemic process in Russia.
During the period from 2018 to 2020, we studied 28,395 conditionally healthy volunteers from various regions of Russia, without age and gender restrictions. Blood serum samples were tested for anti-TBE virus IgG antibodies. All volunteers completed questionnaires to collect demographic data, information about residence, TBE vaccination, and tick bites.
Our study included participants from non-endemic (Moscow and the Republic of Dagestan) and endemic regions (Moscow Region, St. Petersburg, Leningrad Region, Novosibirsk Region, Khabarovsk Region). In regions with the highest protection against TBE, such as Novosibirsk Region and Khabarovsk Region, the proportions of individuals with seropositive and protective antibody titers were below 45% and 35%, respectively. The lowest rate of protective immunity was found among children (25.4% in Novosibirsk Region and 22% in Khabarovsk Region) and those aged 60 and older (27.3% and 25.1%, respectively). Situation was even more challenging in St. Petersburg and Leningrad Region, where the rate of protective antibody titers ranged from 4.3% to 8.7%. The highest vaccination coverage was found among volunteers from Novosibirsk Region and Khabarovsk Region: 32.5% and 27.4%. In St. Petersburg and Leningrad Region, vaccination coverage was ranged from 10.4% to 11.3%, while in other regions it was below 6%. The rates of post-vaccine protective immunity were 63.1% in Khabarovsk Region, 71.6% in Novosibirsk Region and up to 50% in other regions. The rates of post-infection immunity were 33.4% in Novosibirsk Region, 42.4% in Khabarovsk Region and below 12% in other regions.
Our results demonstrated diversity of population immunity level and structure in different regions of Russia. The analysis showed that study participants are at risk of TBE infection, especially high in endemic regions, due to insufficient level of population immunity, vaccination coverage, and protective post-vaccine immunity.
蜱传脑炎(TBE)是俄罗斯一项重大的公共卫生挑战。疫苗接种是控制TBE最有效的措施之一。我们研究的目的是在俄罗斯流行过程特征的背景下,评估抗TBE病毒人群免疫力的状况,包括人工疫苗接种后和自然感染后的免疫力。
在2018年至2020年期间,我们研究了来自俄罗斯不同地区的28395名条件健康的志愿者,无年龄和性别限制。检测血清样本中的抗TBE病毒IgG抗体。所有志愿者填写问卷以收集人口统计学数据、居住信息、TBE疫苗接种情况和蜱叮咬情况。
我们的研究包括来自非流行地区(莫斯科和达吉斯坦共和国)和流行地区(莫斯科地区、圣彼得堡、列宁格勒地区、新西伯利亚地区、哈巴罗夫斯克地区)的参与者。在对TBE防护最高的地区,如新西伯利亚地区和哈巴罗夫斯克地区,血清学阳性和具有保护性抗体滴度的个体比例分别低于45%和35%。在儿童(新西伯利亚地区为25.4%,哈巴罗夫斯克地区为22%)和60岁及以上人群(分别为27.3%和25.1%)中发现保护性免疫力最低。在圣彼得堡和列宁格勒地区情况更严峻,保护性抗体滴度率在4.3%至8.7%之间。新西伯利亚地区和哈巴罗夫斯克地区的志愿者疫苗接种覆盖率最高:分别为32.5%和27.4%。在圣彼得堡和列宁格勒地区,疫苗接种覆盖率在10.4%至11.3%之间,而在其他地区则低于6%。哈巴罗夫斯克地区疫苗接种后保护性免疫力率为63.1%,新西伯利亚地区为71.6%,其他地区高达50%。感染后免疫力率在新西伯利亚地区为33.4%,哈巴罗夫斯克地区为42.4%,其他地区低于12%。
我们的结果表明俄罗斯不同地区人群免疫水平和结构存在差异。分析表明,由于人群免疫力水平、疫苗接种覆盖率和疫苗接种后保护性免疫力不足,研究参与者有感染TBE的风险,在流行地区尤其高。